MedPath
NMPA Approval

Indobufen Tablets

国药准字H20243224

February 23, 2024

Drug Information

吲哚布芬片

片剂

0.2g

化学药品

February 23, 2024

Company Information

Applicant Company

长沙高新开发区金洲大道67号瑞芯企业广场(原名跨境电商产业园)瑞芯2栋2101、2102、2105、2106号房

Manufacturing Company

浙江省金华市婺城区汤溪镇永湖街788号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吲哚布芬片 - NMPA 批准文号 | MedPath